Neuropharmacology

SJR Rank #2,239H-index: 206SJR: 1.568Best quartile: Q1APC: US$4,300
Journal website: aims, scope and author guidelines
Publisher

Elsevier Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.40.81.21.6

Subject Categories

  • Cellular and Molecular NeuroscienceQ1
  • PharmacologyQ1

Areas: Neuroscience · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Neuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on BehaviorReceptor Mechanisms and SignalingIon channel regulation and functionNeuropeptides and Animal PhysiologyPain Mechanisms and TreatmentsNicotinic Acetylcholine Receptors StudyNeuroendocrine regulation and behaviorMemory and Neural MechanismsStress Responses and Cortisol

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0200400600800

Documents per Year

20222025095190285380

Detailed Information

ISSN

0028-3908, 1873-7064

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

5.27

References per Document

76.00

Coverage

1962-2026

Scope

Neuropharmacology publishes high quality, original research within the discipline of neuroscience. The emphasis of Neuropharmacology is on the study and understanding of the actions of known exogenous and endogenous chemical agents on neurobiological processes in the mammalian nervous system. Work with non-mammalian and invertebrate species may be considered in exceptional circumstances. The journal does not usually accept clinical research, although neuropharmacological studies in humans may be considered on the condition that they provide novel insight into either the actions of drugs and/or neurobiological mechanisms. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Similarly, manuscripts describing the use of natural products will only be considered if the active ingredient is known and disclosed.

Metrics from SCImago Journal Rank 2025. View on SCImago